Abstract
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs. Classification of the cell lines based solely on the observed patterns of gene expression revealed a correspondence to the ostensible origins of the tumours from which the cell lines were derived. The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect. Specific features of the gene expression patterns appeared to be related to physiological properties of the cell lines, such as their doubling time in culture, drug metabolism or the interferon response. Comparison of gene expression patterns in the cell lines to those observed in normal breast tissue or in breast tumour specimens revealed features of the expression patterns in the tumours that had recognizable counterparts in specific cell lines, reflecting the tumour, stromal and inflammatory components of the tumour tissue. These results provided a novel molecular characterization of this important group of human cell lines and their relationships to tumours in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Stinson, S.F. et al. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res. 12, 1035–1053 (1992).
Myers, T.G. et al. A protein expression database for the molecular pharmacology of cancer. Electrophoresis 18, 647– 653 (1997).
Weinstein, J.N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343– 349 (1997).
Monks, A., Scudiero, D.A., Johnson, G.S., Paull, K.D. & Sausville, E.A. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des. 12, 533–541 ( 1997).
Paull, K.D. et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl Cancer Inst. 81, 1088 –1092 (1989).
Weinstein, J.N. et al. Neural computing in cancer drug development: predicting mechanism of action. Science 258, 447– 451 (1992).
van Osdol, W.W., Myers, T.G., Paull, K.D., Kohn, K.W. & Weinstein, J.N. Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents. J. Natl Cancer Inst. 86, 1853–1859 ( 1994).
DeRisi, J.L., Iyer, V.R. & Brown, P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680– 686 (1997).
Iyer, V.R. et al. The transcriptional program in the response of human fibroblasts to serum. Science 283, 83– 87 (1999).
Brown, P.O. & Botstein, D. Exploring the new world of the genome with DNA microarrays. Nature Genet. 21 ( suppl.), 33–37 (1999).
Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nature Genet. 24, 236– 244 (2000).
Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009– 5013 (1998).
Der, S.D., Zhou, A., Williams, B.R. & Silverman, R.H. Identification of genes differentially regulated by interferon-α, -β or -γ or using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623 –15628 (1998).
Alon, U. et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl Acad. Sci. USA 96, 6745– 6750 (1999).
Wang, K. et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229, 101– 108 (1999).
Tamayo, P. et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl Acad. Sci. USA 96, 2907– 2912 (1999).
Shalon, D., Smith, S.J. & Brown, P.O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6, 639–645 (1996).
Eisen, M.B. & Brown, P.O. DNA arrays for analysis of gene expression . Methods Enzymol. 303, 179– 205 (1999).
Sokal, R.R. & Sneath, P.H.A. Principles of Numerical Taxonomy (W.H. Freeman, San Francisco, 1963).
Hartigan, J.A. Clustering Algorithms (Wiley, New York, 1975).
Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863– 14868 (1998).
del Marmol, V. & Beermann, F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381, 165–168 (1996).
Kawakami, Y. et al. The use of melanosomal proteins in the immunotherapy of melanoma . J. Immunother. 21, 237– 246 (1998).
Cailleau, R., Olive, M. & Cruciger, Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911–915 (1978).
Brinkley, B.R. et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res. 40, 3118– 3129 (1980).
Nesland, J.M., Holm, R., Johannessen, J.V. & Gould, V.E. Neuroendocrine differentiation in breast lesions. Pathol. Res. Pract. 183, 214–221 ( 1988).
Davies, J.A. & Garrod, D.R. Molecular aspects of the epithelial phenotype. Bioessays 19, 699– 704 (1997).
Garrod, D., Chidgey, M. & North, A. Desmosomes: differentiation, development, dynamics and disease. Curr. Opin. Cell Biol. 8, 670– 678 (1996).
Cowin, P. & Burke, B. Cytoskeleton-membrane interactions . Curr. Opin. Cell Biol. 8, 56– 65 (1996); erratum: 8, 244 (1996).
Litvinov, S.V. et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J. Cell Biol. 139, 1337–1348 (1997).
Helmle-Kolb, C. et al. Na/H exchange activities in NHE1-transfected OK-cells: cell polarity and regulation. Pflugers Arch. 425, 34–40 (1993); erratum: 427 , 387 (1994).
Manfruelli, P., Arquier, N., Hanratty, W.P. & Semeriva, M. The tumor suppressor gene, lethal(2)giant larvae (1(2)g1), is required for cell shape change of epithelial cells during Drosophila development. Development 122, 2283–2294 (1996).
Lincecum, J.M., Fannon, A., Song, K., Wang, Y. & Sassoon, D.A. Msh homeobox genes regulate cadherin-mediated cell adhesion and cell-cell sorting. J. Cell Biochem. 70, 22–28 (1998).
Hackett, A.J. et al. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J. Natl Cancer Inst. 58, 1795– 1806 (1977).
Rutka, J.T. et al. Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res. 46, 5893– 5902 (1986).
Nguyen, H., Hiscott, J. & Pitha, P.M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8, 293– 312 (1997).
Moscow, J.A., Schneider, E., Ivy, S.P. & Cowan, K.H. Multidrug resistance. Cancer Chemother. Biol. Response Modif. 17, 139– 177 (1997).
Smith, H.S. & Hackett, A.J. The use of cultured human mammary epithelial cells in defining malignant progression. Ann. N Y Acad. Sci. 464, 288–300 ( 1986).
Rutka, J.T. et al. Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol. 75, 92–103 (1987).
Ronnov-Jessen, L., Petersen, O.W. & Bissell, M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69–125 ( 1996).
Perou, C.M et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212–9217 (1999).
Bonner, R.F. et al. Laser capture microdissection: molecular analysis of tissue . Science 278, 1481–1483 (1997).
Sgroi, D.C. et al. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 59, 5656– 5661 (1999).
Acknowledgements
We thank members of the Brown and Botstein labs for helpful discussions. This work was supported by the Howard Hughes Medical Institute and a grant from the National Cancer Institute (CA 077097). The work of U.S. and J.N.W. was supported in part by a grant from the National Cancer Institute Breast Cancer Think Tank. D.T.R is a Walter and Idun Berry Fellow. M.B.E. is an Alfred P. Sloan Foundation Fellow in Computational Molecular Biology. C.M.P. is a SmithKline Beecham Pharmaceuticals Fellow of the Life Science Research Foundation. P.O.B. is an Associate Investigator of the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ross, D., Scherf, U., Eisen, M. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24, 227–235 (2000). https://doi.org/10.1038/73432
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/73432